PUBLISHER: The Business Research Company | PRODUCT CODE: 1942628
PUBLISHER: The Business Research Company | PRODUCT CODE: 1942628
COVID-19 detection test kits and consumables are used to identify SARS-CoV-2 infection. These kits commonly rely on reverse transcription polymerase chain reaction (RT-PCR) technology to detect the virus's genetic material.
The COVID-19 detection test kits and consumables market covered in this report is categorized by kits into viral load testing kits (qPCR and RT-PCR), virus-neutralizing assay kits, antibody detection kits (ELISA), viral antigen detection test kits, and others. It is further segmented by consumables into swabs, tubes, viral transport media, reagents, and other consumables, and by specimen type into nasal and throat swabs, blood, sputum, and nasal aspirates. The end users include hospitals, clinics, public health laboratories, private and commercial laboratories, physicians' laboratories, research institutes, and others.
Tariffs are impacting the covid-19 detection test kits and consumables market by increasing the cost of imported reagents, swabs, tubes, and test kits, particularly in regions like Asia-Pacific and North America. High tariffs on imported consumables have raised production costs and impacted supply chains, slowing deployment in hospitals, clinics, and public health laboratories. On the positive side, tariffs have encouraged domestic production of test kits and consumables, boosting local manufacturing capabilities and promoting innovation in diagnostic technologies.
The covid-19 detection test kits and consumables market research report is one of a series of new reports from The Business Research Company that provides covid-19 detection test kits and consumables market statistics, including covid-19 detection test kits and consumables industry global market size, regional shares, competitors with a covid-19 detection test kits and consumables market share, detailed covid-19 detection test kits and consumables market segments, market trends and opportunities, and any further data you may need to thrive in the covid-19 detection test kits and consumables industry. This covid-19 detection test kits and consumables market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The covid-19 detection test kits and consumables market size has grown strongly in recent years. It will grow from $8.35 billion in 2025 to $8.94 billion in 2026 at a compound annual growth rate (CAGR) of 7.1%. The growth in the historic period can be attributed to initial shortage of covid-19 test kits, rising demand in hospitals and public health labs, reliance on conventional rt-pcr testing, limited supply of swabs and reagents, increasing awareness of pandemic monitoring.
The covid-19 detection test kits and consumables market size is expected to see rapid growth in the next few years. It will grow to $13.23 billion in 2030 at a compound annual growth rate (CAGR) of 10.3%. The growth in the forecast period can be attributed to development of rapid and high-throughput testing kits, expansion of private and commercial labs, integration of digital reporting and cloud-based data management, adoption of multiplex and combination test kits, growing investment in research and diagnostic infrastructure. Major trends in the forecast period include rising demand for rapid and accurate covid-19 detection kits, expansion of consumables such as swabs, reagents, and viral transport media, increased adoption of multiplex and combination test kits, growing use of point-of-care and rapid antigen testing, focus on standardization and quality compliance across laboratories.
The expansion of government initiatives is anticipated to support the growth of the COVID-19 detection test kits and consumables market going forward. Government initiatives include policies, programs, and actions implemented by authorities to address public health challenges and promote population well-being. Such initiatives play a critical role in facilitating the effective deployment of COVID-19 detection test kits and consumables, supporting global efforts to manage and mitigate the impact of the pandemic. For example, in 2025, according to the American Medical Association, a US-based association, health expenditures in the United States increased by 7.5% in 2023, reaching $4.9 trillion, or approximately $14,570 per person. As a result, growing government initiatives are reinforcing expansion within the COVID-19 detection test kits and consumables market.
Leading companies operating in the COVID-19 detection test kits and consumables market are increasingly focusing on at-home molecular diagnostic platforms to improve testing accuracy, convenience, and timely infection detection. Molecular tests identify specific genetic material such as DNA or RNA to detect infectious agents. For example, in April 2023, Lucira Health, a US-based medical technology company, launched the Lucira COVID-19 & Flu Home Test, the first OTC at-home combination molecular test authorized by the FDA for SARS-CoV-2 and influenza A/B detection. The single-use test delivers results in approximately 30 minutes and offers PCR-comparable performance, enabling users to differentiate between COVID-19 and flu infections at home.
In December 2023, Danaher Corporation, a US-based provider of life sciences instruments, diagnostics, and advanced scientific tools, acquired Abcam plc for an undisclosed amount. With this acquisition, Danaher aims to incorporate Abcam's offerings into its life sciences and diagnostics platform to strengthen its consumables portfolio and enhance support for research and therapeutic discovery. Abcam plc is a UK-based company specializing in the production of COVID-19 detection test kits and related consumables, including multiple SARS-CoV-2 antibody ELISA kits.
Major companies operating in the covid-19 detection test kits and consumables market are Cepheid, BGI Genomics, Abbott Laboratories, bioMerieux SA, Bio-Rad Laboratories, F. Hoffmann-La Roche, GenMark Diagnostics, Mylab Discovery Solutions, Qiagen, Quidel Corporation, Randox Laboratories, SD Biosensor, Seegene Inc., Shenzhen Bioeasy Biotechnology, Thermo Fisher Scientific inc., BioMednomics, Getein Biotech, Sensing Self Ltd., Hangzhou Biotest Biotech Co. Ltd, AmonMed Biotechnology Co., Beijing Tigsun Diagnostics Co Ltd., BioMaxima S.A., CTK Biotech, Hunan Lituo Biotechnology Co., Vivacheck Lab, MD Solutions, FastSense Diagnostics, Altona Diagnostics, Siemens AG, Agilent Technologies Inc., Seasun Biomaterials, BTNX Inc., Rapiim, Canon Medical Systems Corporation, Cellspect Co. Ltd., iHealth Labs Inc., InBios International Inc., iXensor Co. Ltd., Jiangsu Medomics medical technology Co Ltd., Maxim Biomedical Inc., Mologic Inc., OraSure Technologies Inc., OSANG LLC, PHASE Scientific International Ltd., Watmind USA, Xiamen Boson Biotech Co. Ltd.
North America was the largest region in the COVID-19 detection test kits and consumables market in 2025. The regions covered in the covid-19 detection test kits and consumables market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the covid-19 detection test kits and consumables market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The COVID-19 detection test kits & consumables market consists of sales of nucleic acid amplification tests (NAATs) and antigen tests. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
COVID-19 Detection Test Kits and Consumables Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses covid-19 detection test kits and consumables market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for covid-19 detection test kits and consumables ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The covid-19 detection test kits and consumables market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.